Part A: Crossover IM then IV dosing with SPL026 in psychedelic experienced, healthy volunteers.~PART B: IM dosing only with SPL026 in less experienced/psychedelic naive, healthy volunteers.
The goal of this clinical trial is to test SPL026 given via injection into a muscle in healthy volunteers.